About Petrichor
Petrichor is a private equity firm founded in 2017. It is primarily based in New York City, United States.
Overall Petrichor portfolio has seen 4 IPOs and 5 acquisitions, namely ClearPoint Neuro, ITM and Aurion Biotech. A lot of funds co-invest with Petrichor, with names like PTC Therapeutics sharing a substantial percentage of its portfolio.
Petrichor has a team of 8 people, including 2 partners.
Key Metrics
Petrichor's Portfolio
They have invested in a total of 18 companies. Their most recent investment was in Geneoscopy (Series C round) on Jan 08, 2025. Here is the most recent investment by Petrichor:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Jan 08, 2025 | Series C | 6380 | ||
Apr 16, 2024 | Series C | 3431 | ||
Mar 01, 2023 | Series A | 2117 | and 6 others | |
Jan 11, 2023 | Series B | 9857 | - |
Here is the portfolio snapshot of Petrichor:
Investments by Year
The maximum number of investments were made in 2023
Team profile of Petrichor
Petrichor has a team of 8 members including 2 Partners and 1 Principal located in United States. Petrichor's team does not sit on the board of any company as of now.Here is a list of all team members in Petrichor:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | New York City | - | - | |
Partner | New York City | - | - | |
Principal | New York City | - | - | |
Associate | New York | - | - | |
Associate | New York | - | - | |
Associate | New York | - | - |
Co-investors of Petrichor
Over the past 9 years, 21 investors have co-invested in Petrichor's portfolio companies.
- Top Co-investors of Petrichor: 21 investors entered a company along with Petrichor. These include investors like PTC Therapeutics (2 companies).
Petrichor News
•
Petrichor appoints life sciences veteran as operating partnerPrivate Equity Wire•Apr 08, 2026•Petrichor
•
Fennec Pharmaceuticals partially repays its outstanding convertible debt facilitySeeking Alpha•Dec 19, 2024•Fennec Pharma, Petrichor
•
Avalo secures new anti-inflammatory drug through acquisition of AlmatabioInvesting•Mar 28, 2024•Avalo Therapeutics, AlmataBio, Commodore Capital, TCG Crossover and 10 others
•
•
Egdon Resources NSTA Condition has now been satisfied for acquisition by PetrichorDirectorsTalk Interviews•Aug 29, 2023•Egdon Resources, Petrichor, Petrichor
•
Egdon Resources acquisition by Petrichor Partners agreed for £26.64 millionDirectorsTalk Interviews•May 17, 2023•Egdon Resources, Petrichor, Com.au
•
Vero Biotech raises $30M for tankless nitric oxide delivery systemDrug Delivery Business•Jan 11, 2023•Vero Biotech, Petrichor, Petrichor, Covington & Burling
•
Palvella Therapeutics Raises Up To $37.7M Series D FinancingFinSMEs•Jan 09, 2023•Palvella Therapeutics, Petrichor, Gore Range Capital, Samsara BioCapital and 6 others
•
Fennec Pharmaceuticals Announces Second Closing of $20 Million Investment from PetrichorCalgary Herald•Sep 26, 2022•Fennec Pharma, Petrichor
•
Fennec Pharmaceuticals Announces Up to $45 Million Investment From PetrichorFinancial Post•Aug 01, 2022•Fennec Pharma, Petrichor
